← All Sponsors
SPONSOR

Continuity Biosciences, LLC

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Pancreatic Adenocarcinoma Non-resectable
NCT07481383 Phase 1
Recruiting

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

Pancreatic Adenocarcinoma Non-resectable
United States View Trial →